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Lipids (fats) are essential and diverse families of molecules 
that play structural, energy storage and signalling roles. They 
are connected through complex metabolic pathways, which 
comprise linked series of enzymatic reactions (several are 
outside cells, e.g. PLA2 isoforms, autotaxin). Thus, lipids can 
be substrates, products or intermediates. It has been estimated 
that there are approximately 3–5000 different lipid species in 
mammalian cells although the true number is still unknown and 
extremely difficult to reliably measure1,2. In recent years, great 
advances have been made in our ability to experimentally deter-
mine the elemental composition and quantitation of lipid levels 
in biological samples, with the advent of rapid scanning benchtop 
mass spectrometers (MS), in particular high-resolution configu-
rations such as Orbitrap, and ToF. Liquid chromatography-MS, 
either tandem or high resolving power, interfaced with process-
ing pipelines such as Lipid Data Analyser (LDA), Lipid-
Finder, LipidHunter, MS-Dial, XCMS and many others makes 
it feasible to simultaneously monitor the dynamic changes in 
hundreds of lipid molecular species in biological samples3–7.
As the quantity and detail of quantitative lipid data continue 
to grow it has become considerably more challenging to inter-
pret the complex sets of changes within the lipidome8. Relevant 
biological perturbations usually happen not at the level of a sin-
gle lipid molecular species in isolation, but as broad sets of 
changes over entire lipid classes and subclasses9. For example, 
a group of phosphatidylcholines will tend to change together in 
the same direction, since they are being regulated by the same 
enzyme isoform(s). This introduces characteristic patterns in the 
data that can reveal important clues as to the underlying level of 
genetic and transcriptomic regulation. Consequently, there is a 
need for software tools to automate and facilitate biosynthetic 
pathway scale analyses with lipids grouped according to structural 
motifs. Nguyen et al. and Hann et al. described the analysis of 
quantitative lipidomics datasets at pathway levels10–12. Here, we 
have integrated the biosynthetic metabolic levels into BioPAN. 
So, BioPAN combines current knowledge of lipid metabolism 
with a statistical analysis functionality, by comparing two bio-
logical conditions to identify activated or suppressed pathways, 
and present the results in an interactive graphical display. BioPAN 
works with data resolved to the level of individual lipid molecu-
lar species, but it can aggregate results at the subclass level to 
simplify the interpretation. Mammalian reaction information 
is converted into a metabolic pathway within BioPAN, allow-
ing it to predict the most likely lipid transforming genes modu-
lated by an experiment, to provide direct biological insight and 
generate hypotheses that can be experimentally tested.
BioPAN is openly available on the LIPID MAPS® Lipidomics 
Gateway, at https://lipidmaps.org/biopan/. The tool is designed 
to allow users to upload and analyse their own data, and exam-
ple datasets are also provided for evaluation. BioPAN is fully 
integrated with LipidLynxX, allowing users to convert differ-
ent naming (short notation) conventions from diverse software 
inputs to be able to make it readable on BioPAN. Addition-
ally, LipidLynxX will convert lipid results with fatty acid posi-
tion, double bond location, and stereochemistry into a sum 
composition of carbon number and double bond equivalents. 
For example, DAG (16:0/20:1(Z11)), is converted by Lipid-




The statistical model used in BioPAN was originally described 
by Nguyen et al.10. In brief, BioPAN uses data from replicated 
quantitative lipidomics experiments with two biological experi-
ments: a condition of interest (treated) and a control condition. 
BioPAN calculates statistical scores for all possible lipid path-
ways to predict which are active or suppressed in the treated 
samples compared to the control set.
The BioPAN workflow relies on the calculation of the Z-score, 
which considers the mean and the standard deviation of the 
experiment assuming a normally distributed data of lipid sub-
classes. A probability function (P) is computed and subtract-
ing from one to obtain Q, which in turn is the probability that a 
Z-score is due to chance. The Z-score is then used to predict 
whether a particular reaction is significantly (p < 0.05) chang-
ing between control and treated conditions. Z-scores for all 
reactions in a pathway are combined using a cumulative func-
tion (CDF) to give a global pathway Z-score The set of equa-
tions used to calculate Z-scores are presented and discussed 
elsewhere10. Changing reactions are classified as activated or 
suppressed depending upon the direction of change. BioPAN, 
by default, calls a reaction or pathway as significantly modified 
at a level of p < 0.05 (Z > 1.645).
Operation
BioPAN is implemented as an open access web-based tool. 
The front end uses HTML, jQuery (v3.5.1) for the interface and 
the Cytoscape.js library (v3.10.2)13 to draw and manipulate the 
results graphs. The server-side code uses PHP (v7.4.11) for 
request handling and R (v4.0.2) for data processing and 
statistical analysis. BioPAN runs on all modern web browsers 
and is available at https://lipidmaps.org/biopan/.
BioPAN allows uploading of lipidomics datasets containing 
quantitative data from two different experiments or conditions 
(e.g. wild type against treated/knock-out). The use of BioPAN is 
simple and intuitive with a user-friendly interface. The data files 
should have minimum two replicas per condition, as BioPAN 
compares the changes between the experiments. BioPAN takes 
an input file in .csv (Comma-Separated Values). The first column 
on the file should include the lipid abbreviation subclass fol-
lowed by the notation e.g. PC 38:4, PC 18:0_20:4, PC 18:0/20:4, 
or PC 18:0/20:4(5Z,8Z,11Z,14Z), for glycerophopholipids, glyc-
erolipids, and sterol lipids. Sphingolipid molecular species writ-
ten as e.g. d18:1/20:4, or 18:1;O2/20:4, where 18:1;O2 is the 
sphingosine base and 20:4 is the N-acyl chain liked to the sphin-
gosine base are also recognised in BioPAN. Non-conventional 
nomenclature like DG(aa-34:0, DG(ea-34:1) is not recognised 
by BioPAN and the user manually need to change the lipid sub-
class abbreviation14. There are additional instructions about 
the structure of the data file following the link https://lipidmaps.
org/biopan/doc/step1.html, which directs the user to each lipid 
subclass abbreviation in LIPID MAPS® Lipidomics Gateway.
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The first step in BioPAN is to load a file of quantitative lipid-
omics data. After uploading, BioPAN uses the LipidLynxX15 
tool to cross-match some lipid names into the LIPID MAPS® 
Lipidomics Gateway nomenclature style according to the guide-
lines from COMP_DB (https://www.lipidmaps.org/resources/
tools/bulk_structure_searches_documentation.php)9,14,16. BioPAN 
then classifies the submitted lipids as either unrecognised, proc-
essed, or unprocessed. Unrecognised molecular species are 
lipids whose subclasses are not included into BioPAN database, 
while unprocessed species are part of BioPAN, but were not 
associated with any reactions. BioPAN’s database was manu-
ally collated followed by a validation using available literature. 
The database currently contains 94 lipid reactions identi-
fied in mammals, covering 41 lipid subclasses. Only processed 
molecular species, e.g. those which can be associated with at 
least one reaction, are used for downstream analysis.
The second step within BioPAN requires users to associate each 
sample with a condition. (e.g. sample names: control1, treated1, 
or control2, treated2, and so on, with their respective replicates). 
Each condition requires a minimum of two replicas (three or 
more replicas per condition are strongly recommended). Once 
assignments have been made, BioPAN searches for reactions 
and pathway changes between these. Following analysis com-
pletion, the user is directed to the results page (Figure 1). The 
main viewport shows an interactive graph comprising lipids 
and reactions assigned to the lipids included in the input file 
uploaded. The user can select how the pathways are displayed 
in the interactive graph by manually moving the nodes in the 
graph, while the link between product and substrate is main-
tained. Thus, providing a view of all possible reaction pathways. 
The side panel provides a legend for the graph and controls to 
modify the specifics of the analysis performed and the level 
of detail in the graph. The legend describes the shape of the 
nodes, which denote the lipid subclass, and the colour of the 
nodes represent the pathway status (active/suppressed or none). 
Each arrow between two nodes (lipid subclass/lipid molecu-
lar species) depicts the reaction direction between the two 
Figure 1. Main results page view for BioPAN. Pathways are displayed as an interactive graph at the centre of the screen. Users have 




lipids. The colour of the arrows depends on the value of the 
Z-score (see the Implementation section), where green indicates 
a positive Z-score and purple negative, as shown in Figure 1. 
The user can click in the arrows connecting each node and a 
pop table is generated by BioPAN showing all the lipid molecu-
lar species selected and non-selected in the reaction between 
two nodes (see Extended Data, Table S-1). Selecting the arrow 
is only functional when selecting the lipid subclass level in the 
pathway options (described in the section below). Addition-
ally, information on lipid subclasses and molecular species 
are available by clicking on the nodes, linking to the LMSD 
database (https://www.lipidmaps.org/data/structure/index.php).
The bottom panel shows a tabular view of statistically significant 
(p < 0.05 equivalent to Z-score > 1.645) results.
Display options. The pathway options on the left of the screen 
allow users to customize the display of results in the graph. 
BioPAN arbitrarily chooses two conditions to compare (condi-
tion of interest and control condition, see Figure 1. The user 
can change conditions to compare using the drop-down menu 
(Figure 1). Users can choose to view pathways based on either 
the lipid subclass or on the fatty acyl composition. They can also 
choose which pathways to highlight in the main graph. Users can 
opt for either significantly active (condition of interest > con-
trol) or significantly suppressed (condition of interest < control) 
pathways. Where the same reaction can participate in multiple 
pathways, users can also choose to view only the most active 
(or most suppressed) pathway. This will highlight only the path-
way with the highest individual pathway level Z-score for path-
ways containing reactions where a substrate is the starting agent 
in a reaction. In other words, selecting most active or most 
suppressed status still follow the rule for the active/suppressed 
status in terms of colours and Z-scores as discussed above. How-
ever, the Z-scores in an active/suppressed single reaction 
(e.g. PClDG) are compared for substrates, intermediates, and 
products following each step of the pathway. For example, in 
the cerebral cortex (with pathway options: active status, sub-
class level, reaction subset of lipid data, 0.05 p value, no paired-
data), reactions within multiple pathways like PClDGlMG 
and PClDGlPA. PC is the initial substrate and have indi-
vidual reaction Z-scores of 3.083 (PClDG), 2.054 (DGlMG), 
and -0.408 (DGlPA). It can be observed above that PClDG 
is common for the first step in both pathways, and then BioPAN 
selects the most active reaction with the highest Z-score for 
the second part of the pathway. So, the Z-score of DGlMG 
is greater than the score for DGlPA. Thus, PClDGlMG 
is most active pathway compared to PClDGlPA. There 
might be more than one active pathway with one lipid-initiated 
substrate (e.g. DGlTG, DGlPElPS, and DGlPClCL), 
the same principle is applied, and BioPAN will consider only 
one of those pathways as most active.
Users can also choose to have the nodes in the graph aggre-
gated into lipid subclasses, or they can view individual lipid 
molecular species. All views allow for filtering to display only a 
user-selected subset of lipids. These can be chosen either from 
a tree of checkboxes for each subclass, or using a free text 
search, allowing users to focus on particular lipids of interest (see 
Extended Data, section S-2, Figure S-1). Alternatively, the user 
can opt to view only reaction chains which occur within the con-
text of a set of curated named pathways stored within BioPAN 
(e.g. biosynthesis of PC and Kennedy pathway). Changing 
pathway options affects both the graph and results tables.
Calculation options. Under the Pathway Calculation section, the 
user can control details of the statistical calculation. They can 
alter the groups to be compared as well as changing the thresh-
old for significance from the default of p < 0.05. If replicates in 
the uploaded data were generated as matched pairs (e.g. control 
and treated sample coming from the same animal) then the cal-
culation can also take this into account in the t-test step of the 
analysis.
Exporting results. Results of the statistical analysis of 
active/suppressed pathways are presented in four tables at the 
bottom of the page, where predicted gene changes can be visu-
alized. Export options are also available on the top right corner 
in the BioPAN viewport, where the main graph can be exported 
in several formats (JPEG / PNG / JSON / TXT) and tables 
are exported as TSV files.
Example use case
Lipidomics data from cerebral cortex and liver of young and 
aged mice17 were used here as an example to illustrate how to 
use BioPAN and interpret its results. Ando et al.17 compared 
the lipid profile of different tissues in young and aged mice with 
the aim of detecting age-related as well as tissue-specific lipid 
modifications. The authors clustered alkylacyldiacylglycerols 
and deoxysphingolipids molecular species, reporting accumu-
lation of deoxysphingolipids and ether-linked diacylglycerols 
in both tissues. Additional lipid subclasses were measured from 
Ando et al. (Additional information file 3), but those results 
were not discussed in the original publication10. The results from 
Ando et al. are used here to show how BioPAN can provide a 
wider analysis of the lipid level changes and the interrelation 
between different lipid subclasses.
The datasets from the original paper, were downloaded as 
TXT files from Metabolomics Workbench (Project ID PR000713, 
Studies ID ST001065 and ST001066) and are available as 
underlying data (see data availability section). Each file was 
imported as described in the method implementation sec-
tion. Pathway options and pathway calculations settings were 
as follows: Type: Lipid; Status: Active; Level: Lipid subclass; 
Subset of lipid data: Reactions; Condition of interest: Aged; 
Control condition: Young; p value: 0.05; Paired data: No.
The lipid network at the lipid subclass level is shown in 
Figure 2A for the liver and Figure 2B for the cerebral cortex. 
The lipid pathway graph allows the user to quickly spot trends 
and differences between the two sets of samples. Figure 2 shows 
that reactions using ether-linked diacylglycerol (O-DG) as a 
substrate are suppressed in both liver and cerebral cortex in 
old versus young, which agrees with the reported accumula-
tion of this particular lipid subclass by Ando et al.17. Here, 
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BioPAN also found tissue-specific differences in lipid metabo-
lism. For example, the reaction pathway results of aged mouse 
liver suggest active metabolism leading to accumulation of 
triacylglycerols (TG, Z-score = 2.301), a form of energy stor-
age, contrary to a catabolic metabolism of TG observed in the 
cerebral cortex (Z-score = -2.612).
Figure 2. BioPAN lipid networks. Lipid network graphs exported from BioPAN for the liver (A) and the cerebral cortex (B) of aged mice 
compared to young mice17. Green nodes correspond to active lipids and green shaded arrows to active pathways. Reactions with a positive Z 
score have green arrows while negative Z scores are coloured purple. Pathways options: aged condition of interest, young control condition, 
lipid type, active status, subclass level, reaction subset of lipid data, p value 0.05, and no paired-data.
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BioPAN also shows more differences in the metabolism of sphin-
golipids between the tissues. Specifically, in the liver the path-
way is shifted towards the formation of ceramide-1-phosphate 
(Cer1P), while in the cerebral cortex sphingolipid metabolism 
points towards the formation of sphingomyelin (SM). Moreover, 
in the liver, glycerophospholipids and lysophospholipids 
synthesis is active with exception of LPA, contrary to what it is 
observed in the cerebral cortex, where glycerophospholipids 
and lysophospholipids pathways are suppressed, but production 
of LPA is favoured.
BioPAN provides tables showing the suggested genes known 
to be involved in each reaction. Table 1 shows the lipid sub-
class active reaction results generated for the liver dataset. 
For example, the pathway PElPClPSlLPS designates the 
genes PEMT, PTDSS1, PLA2G2E, PLA2G2A, PLA2G2F. It 
should be noted that the default nomenclature of the genes in 
BioPAN corresponds to human species. In the example case 
presented here, the lipidomics data was obtained from mice, 
and although most often human and mouse genes are the 
same, there can be subtle differences between species. Thus, 
the user is encouraged to assign the gene according to the spe-
cies in their own study. To aid the user in identifying the species 
each gene in Table 1 has a link that exists in the LIPID MAPS® 
Proteome Database (LMPD) (https://lipidmaps.org/resources/
databases/index.php?tab=lmpd). For example, in Table 1 PEMT 
gene refers to a table containing the name and species of the 
gene, including a unique LMP ID for each gene/species pair. 
Thus, LMP002477 is assigned to the gene Pemt for mouse, 
which converts PE to PC. The status of this pathway might be 
Table 1. BioPAN predicted genes of the lipid active reactions in liver of aged vs young mice. Table contains the active 
reactions chains found by BioPAN according to the Z-score values. Several genes are predicted as being involved in the current 
status of each reaction based on their function. Pathway options: aged condition of interest, young control condition, lipid type, 
active status, subclass level, reaction subset of lipid data, p value 0.05, no paired-data.
lipid subclass active reaction (Aged vs Young)
Reaction chains Z-score Predicted genes
PElPClPSlLPS 3.978 PEMT, PTDSS1, PLA2G2E, PLA2G2A, PLA2G2F 
DGlPClPSlLPS 3.686 CHPT1, PTDSS1, PLA2G2E, PLA2G2A, PLA2G2F 
PElPClLPC 3.519 PEMT, PLA2G2E, PLA2G2A, PLA2G2D, PLA2G2F, PLA2G1B 
LPAlPAlPGlLPG 3.367 AGPAT1, AGPAT2, AGPAT3, AGPAT4, AGPAT5, CDS1, CDS2, PTPMT1, PLA2G4D, PLA2G4F, 
CRLS1 
PElPClPAlPGlLPG 3.179 PEMT, PLD1, PLD2, CDS1, CDS2, PTPMT1, PLA2G4D, PLA2G4F, CRLS1 
DGlPClLPC 3.161 CHPT1, PLA2G2E, PLA2G2A, PLA2G2D, PLA2G2F, PLA2G1B 
PGlLPG 3.077 PLA2G4D, PLA2G4F, CRLS1 
LPAlPAlPSlLPS 2.898 AGPAT1, AGPAT2, AGPAT3, AGPAT4, AGPAT5, CDS1, PTDSS1, PLA2G2E, PLA2G2A, PLA2G2F 
DGlPElLPE 2.815 CEPT1, PLA2G4C 
PElPS 2.700 PTDSS2 
PClPSlLPS 2.657 PTDSS1, PLA2G2E, PLA2G2A, PLA2G2F 
DGlMG 2.507 PNPLA2, PNPLA3 
DGlTG 2.301 DGAT2 
DGlPClPA 2.280 CHPT1, PLD1, PLD2 
dhSMldhCerlCerlCer1P 2.218 SGMS1, SGMS2, DEGS1, DEGS2, CERK 
DGlPA 2.050 DGKA, DGKB, DGKD, DGKE, DGKG, DGKH, DGKI, DGKK, DGKQ, DGKZ 
O-PElO-LPE 1.942 PLA2G4A 
LPAlPAlPI 1.878 AGPAT1, AGPAT2, AGPAT3, AGPAT4, AGPAT5, CDS1, CDS2, CDIPT 
PClLPC 1.843 PLA2G2E, PLA2G2A, PLA2G2D, PLA2G2F, PLA2G1B 
PElPClPAlPI 1.837 PEMT, PLD1, PLD2, CDS1, CDS2, CDIPT 
PSlLPS 1.668 PLA2G2E, PLA2G2A, PLA2G2F 
PElPClCL 1.667 PEMT, TAZ 
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changed by the loss of function or altered activity in any of the 
enzymes involved. Therefore, the list provided by BioPAN might 
help guide integration of lipidomics with proteomics or tran-
scriptomics data as it directly suggests target proteins for 
further analysis.
Looking at fatty acids (FA) pathways at the molecular species 
level with BioPAN (Figure 3) shows the FA network obtained 
for liver and cerebral cortex of aged in comparison to young 
mice. The results show active metabolism towards the produc-
tion of monounsaturated FA 16:1 and polyunsaturated FA 20:4, 
FA 20:5, and FA 22:4 in the cerebral cortex compared to the 
liver. Additionally, BioPAN has highlighted accumulation of 
the long acyl chain, polyunsaturated FA 24:5 in liver, which 
is associated with the activation of the ELOVL2 gene found in 
Table 2. Moreover, the results shown in Table 2 suggest a 
Figure 3. BioPAN fatty acids networks. FA graphs exported from BioPAN tool for the liver (A) and the cerebral cortex (B) of aged mice 
compared to young mice17. Green nodes correspond to active lipids and green shaded arrows to active pathways. Reactions with a positive 
Z score have green arrows while negative Z scores are coloured purple. Pathways options: aged condition of interest, young control 
condition, lipid type, active status, subclass level, reaction subset of lipid data, p value 0.05, and no paired-data.
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general activation of elongases (ELOVL) rather than desatu-
rases (SCD) which was found to be a common trait in both 
tissues.
Conclusion
Modern lipidomics techniques generate a huge amount of data 
and information on many lipid subclasses, making the interpre-
tation of results challenging. BioPAN provides several advan-
tages over simpler analyses of individual lipids. The mapping of 
the lipid network graph provides a bigger picture allowing a new 
perspective on the data where new connections can be made, 
and a study can be moved forward into particular areas of inter-
est. BioPAN offers a quick visualisation of differences in lipid 
pathways in mammal studies as well suggesting genes and 
their enzyme products involved in those differences.
Data availability
Underlying data
The datasets analysed as an example are available at the NIH 
Common Fund’s National Metabolomics Data Repository 
(NMDR) website, the Metabolomics Workbench, https://www.
metabolomicsworkbench.org/ where it has been assigned Project 
ID PR000713 (studies ST001065 and ST001066).






Table 2. BioPAN predicted genes for fatty 
acid active reactions in liver of aged vs young 
mice. Table contains the active reaction chains 
found by BioPAN according to the Z-score values. 
Several genes are predicted as being involved 
in the current status of each reaction based on 
their function. Pathway options: aged condition of 
interest, young control condition, fatty acid type, 
active status, p value 0.05, no paired-data.
fa active reaction (Aged vs Young)
Reaction chains Z-score Predicted genes
FA(22:5)lFA(24:5) 2.108 ELOVL2 
FA(18:3)lFA(20:3) 1.831 ELOVL5, ELOVL7 
Open Science Framework: BioPAN: a web-based tool to explore 
mammalian lipidome metabolic pathways on LIPID MAPS, 
https://doi.org/10.17605/OSF.IO/PKD6B18.
This project contains the modified dataset from Ando et al.17 
according to BioPAN’s requirements:
u    Cerebral cortex dataset: https://osf.io/reavk/
u    Liver dataset: https://osf.io/zd4as/
Extended data
Open Science Framework: BioPAN: a web-based tool to explore 
mammalian lipidome metabolic pathways on LIPID MAPS, 
https://doi.org/10.17605/OSF.IO/PKD6B18.
This project contains the following extended data:
u    Table S1, reaction table.
u    Section S2, filtering and tree checkbox discussion.
u    Figure S1, Filter tool example for acyl chains 38:4 and 
38:5.
Software availability
Software, documentation and tutorial video are available from: 
https://lipidmaps.org/biopan/.
Archived source code at the time of the publication: https://doi.
org/10.17605/OSF.IO/PKD6B18.
The user can try BioPAN locally by following the readme 
instruction file located in: https://osf.io/7g2dx/.
License: GNU GPL 3.0
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Introd ction: A sentence co ld be added to the end of the introd ctor  te t s mmarising the 
o erall objecti e of the presented ork. 
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The article entitled BioPAN: a eb-based tool to e plore mammalian lipidome metabolic 
path a s on LIPID MAPS  described an online tool for is alisation of biological path a s from 
q antitati e lipidomics data. The tool is an important contrib tion to lipidomics data anal sis 
pipeline that co ld help make sense of e er more comple  dataset. 
 
General comments
Well- ritten man script and an interesting contrib tion for those st d ing q antitati e 
lipidomics datasets. 
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With regards to the statistical model sed b  the soft are. Co ld the a thors elaborate on 
hether correction for m ltiple testing is done for p- al e calc lations? In the Path a  
calc lation  section, o ld it be possible to let the ser inp t an  al e for the significance 
threshold, rather than choosing from a fe  drop-do n options? 
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co ld filter for PC 32:1 AND PE 32:1 , or 38:5 OR 38:6 . 
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Ultimatel , the tool relies on information contained in the path a  database. While sing an 
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possible to add an option to e port as ector graphics, .s g for e ample?
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